| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $257.7M | — | +10.4% |
| Cost of Revenue | $144.1M | — | +11.7% |
| Gross Profit | $113.6M | — | +8.8% |
| R&D Expense | $23.3M | — | +0.1% |
| SG&A Expense | $54.4M | — | +19.3% |
| Operating Income | $27.5M | — | -15.1% |
| Pre-tax Income | $26.4M | — | -0.2% |
| Income Tax | $5.3M | — | +0.9% |
| Net Income | $21.1M | — | -0.5% |
| EPS (Basic) | $0.52 | — | -11.9% |
| EPS (Diluted) | $0.51 | — | -13.6% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $388.8M | +2.1% | +266.6% |
| Accounts Receivable | $173.9M | -5.9% | +5.9% |
| Inventory | $193.1M | +2.6% | +32.8% |
| Current Assets | $786.8M | +0.5% | +81.2% |
| Total Assets | $1.80B | -0.4% | +29.9% |
| Current Liabilities | $220.8M |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $51.6M | — | +62.9% |
| Capital Expenditures | $4.1M | — | -3.4% |
| Investing Cash Flow | -$3.8M | — | -402.7% |
| Financing Cash Flow | -$40.1M | — | +6.1% |
| Free Cash Flow | $47.5M | — | +73.2% |
| +30.2% |
| Long-term Debt | $201.0M | -5.4% | -47.8% |
| Total Liabilities | $488.0M | -1.0% | -20.7% |
| Stockholders' Equity | $1.31B | -0.2% | +70.3% |